ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target Raised to $23.00 at Mizuho
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) had its price objective hoisted by analysts at Mizuho from $20.00 to $23.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a “neutral” rating on the biopharmaceutical company’s stock. Mizuho’s price target would indicate a potential upside of 6.04% from the company’s current […]
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) had its price objective hoisted by analysts at Mizuho from $20.00 to $23.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a “neutral” rating on the biopharmaceutical company’s stock. Mizuho’s price target would indicate a potential upside of 6.04% from the company’s current […]
